The group alleges selective use of field trial results to project higher yields and early maturation while ICAR scientists defend the evaluation process as transparent and scientifically sound ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...

After his company, Colossal Biosciences, successfully revived the dire wolf from extinction, he's ready to continue to change ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...

In experiments with cells in lab dishes and with mice, this type of "epigenetic engineering ... the other two being DNA and ...

A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...

JNCASR, Bengaluru, has opened applications for its 2025 Research Programmes in Science and Engineering, including PhD and MS ...

In his new book, neuroscientist Steve Ramirez delves in the fast-growing field of memory manipulation, which is being explored as a treatment for depression and other mental health conditions.